NDC 50090-7468 – Desvenlafaxine Succinate
Desvenlafaxine Succinate 25 mg/1 · Tablet, Film Coated, Extended Release · Oral
Product NDC50090-7468
Product details
- Brand name
- Desvenlafaxine Succinate
- Generic name
- Desvenlafaxine Succinate
- Labeler
- A-S Medication Solutions
- Dosage form
- Tablet, Film Coated, Extended Release
- Route
- Oral
- Marketing category
- ANDA · ANDA204172
- Marketed since
- August 25, 2022
- Listing expires
- December 31, 2026
- Pharmacologic class
- Serotonin and Norepinephrine Reuptake Inhibitor
Active ingredients
- Desvenlafaxine Succinate 25 mg/1
Uses, dosage, side effects and warnings for Desvenlafaxine Succinate →
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 50090-7468-0 | 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (50090-7468-0) | Dec 3, 2024 |
| 50090-7468-1 | 90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (50090-7468-1) | Dec 3, 2024 |
Other Desvenlafaxine Succinate products
- 50090-6894 Desvenlafaxine Succinate 50 mg/1 · Tablet, Film Coated, Extended Release · A-S Medication Solutions
- 71335-1150 Desvenlafaxine Succinate 50 mg/1 · Tablet, Film Coated, Extended Release · Bryant Ranch Prepack
- 71335-1331 Desvenlafaxine Succinate 100 mg/1 · Tablet, Film Coated, Extended Release · Bryant Ranch Prepack
- 71335-2494 Desvenlafaxine Succinate 25 mg/1 · Tablet, Film Coated, Extended Release · Bryant Ranch Prepack
- 68180-592 Desvenlafaxine Succinate 50 mg/1 · Tablet, Film Coated, Extended Release · Lupin Pharmaceuticals, Inc.
- 68180-593 Desvenlafaxine Succinate 100 mg/1 · Tablet, Film Coated, Extended Release · Lupin Pharmaceuticals, Inc.
- 68180-604 Desvenlafaxine Succinate 25 mg/1 · Tablet, Film Coated, Extended Release · Lupin Pharmaceuticals, Inc.
- 68788-8556 Desvenlafaxine Succinate 100 mg/1 · Tablet, Film Coated, Extended Release · Preferred Pharmaceuticals Inc.
- 33342-388 Desvenlafaxine Succinate 50 mg/1 · Tablet, Extended Release · Macleods Pharmaceuticals Limited
- 33342-389 Desvenlafaxine Succinate 100 mg/1 · Tablet, Extended Release · Macleods Pharmaceuticals Limited